Several groundbreaking treatments are reshaping glucose treatment, with Retatrutide, Cagrillintide, Tirzepatide, and Semaglutide being highlighted promising candidates. Retatrutide, a double GIP and GLP-1 site activator, demonstrates substantial weight loss coupled with enhanced glucose regulatio